Ledger.Open graph →
SEC Form D · filed December 21, 2011

PORTOLA PHARMACEUTICALS INC

Offering
$9.0M
Sold
$9.0M
Exemption
—
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

People & firms on this filing (26)

Nicholas Galakatos · Boston, MADirectorJean-Jacques Bienaime · South San Francisco, CADirectorJeff Bird · Palo Alto, CADirectorDavid P. Shapiro · New York, NYDirectorRobert J. Karol · Wayland, MAExecHollings Renton · South San Francisco, CADirectorHenry W. Wolff · South San Francisco, CADirectorPeter R. Gruman · Bellingham, WAExec · DirectorNick Huzar · Renton, WADirectorMichael G. Psaros · New York, NYDirectorRick Rubin · Berkeley, CADirectorJames Topper · Seattle, WADirectorJoseph D. Proto · San Diego, CADirectorFarah Champsi · San Francisco, CADirectorHerbert W. Staniszewski · Wayland, MADirectorRobert H. Davis · Easton, MADirectorAroll Jones · Nashville, TNDirectorW. B. Middlekauff · New Haven, CTDirectorCharles Homcy · South San Francisco, CADirectorRussell Hirsch · Palo Alto, CADirectorWilliam Lis · South San Francisco, CAExec · DirectorJean M. George · Waltham, MADirectorMardi Dier · South San Francisco, CAExecBrian Roundtree · SEATTLE, WADirectorMichael Schmertzler · New Haven, CTDirectorPeggy Phillips · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗